Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tatyana Dalcourt"'
Autor:
Suganth Suppiah, Sheila Mansouri, Yasin Mamatjan, Jeffrey C. Liu, Minu M. Bhunia, Vikas Patil, Prisni Rath, Bharati Mehani, Pardeep Heir, Severa Bunda, German L. Velez-Reyes, Olivia Singh, Nazanin Ijad, Neda Pirouzmand, Tatyana Dalcourt, Ying Meng, Shirin Karimi, Qingxia Wei, Farshad Nassiri, Trevor J. Pugh, Gary D. Bader, Kenneth D. Aldape, David A. Largaespada, Gelareh Zadeh
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive sarcoma, and a lethal neurofibromatosis type 1-related malignancy, with little progress made on treatment strategies. Here, we apply a multiplatform integrated molecular
Externí odkaz:
https://doaj.org/article/e359179956df47019171036b9f6ae239
Autor:
Gelareh Zadeh, Roger Stupp, Saleh Almenawer, Neda Pirouzmand, Nazanin Ijad, Tatyana Dalcourt, Jetan H. Badhiwala, Justin Z. Wang, Shervin Taslimi, Farshad Nassiri
Supplementary Table 1. Additional baseline characteristics of all included studies (randomized and non-randomized). Supplementary Table 2. Cochrane Collaboration tool for assessing risk of bias in randomized trials. Supplementary Table 3. Newcastle O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d2c8bec5b82e68b147a4d347ed164e0
https://doi.org/10.1158/1078-0432.22478832.v1
https://doi.org/10.1158/1078-0432.22478832.v1
Autor:
Gelareh Zadeh, Roger Stupp, Saleh Almenawer, Neda Pirouzmand, Nazanin Ijad, Tatyana Dalcourt, Jetan H. Badhiwala, Justin Z. Wang, Shervin Taslimi, Farshad Nassiri
Purpose:Older patients with glioblastoma (GBM) are underrepresented in clinical trials. Several abbreviated and standard chemoradiotherapy regimens are advocated with no consensus on the optimal approach. Our objective was to quantitatively evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32ba1eba4f28c3b80b21db3f51a07785
https://doi.org/10.1158/1078-0432.c.6530058
https://doi.org/10.1158/1078-0432.c.6530058
Autor:
Neda Pirouzmand, Farshad Nassiri, Tatyana Dalcourt, Nazanin Ijad, Justin Z. Wang, Shervin Taslimi, Roger Stupp, Jetan H. Badhiwala, Saleh A. Almenawer, Gelareh Zadeh
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 26(11)
Purpose: Older patients with glioblastoma (GBM) are underrepresented in clinical trials. Several abbreviated and standard chemoradiotherapy regimens are advocated with no consensus on the optimal approach. Our objective was to quantitatively evaluate